1. Home
  2. SRDX vs VHI Comparison

SRDX vs VHI Comparison

Compare SRDX & VHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • VHI
  • Stock Information
  • Founded
  • SRDX 1979
  • VHI 1932
  • Country
  • SRDX United States
  • VHI United States
  • Employees
  • SRDX N/A
  • VHI N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • VHI Major Chemicals
  • Sector
  • SRDX Health Care
  • VHI Industrials
  • Exchange
  • SRDX Nasdaq
  • VHI Nasdaq
  • Market Cap
  • SRDX 416.1M
  • VHI 447.6M
  • IPO Year
  • SRDX 1998
  • VHI N/A
  • Fundamental
  • Price
  • SRDX $29.00
  • VHI $15.73
  • Analyst Decision
  • SRDX Buy
  • VHI Sell
  • Analyst Count
  • SRDX 2
  • VHI 1
  • Target Price
  • SRDX $43.00
  • VHI $12.00
  • AVG Volume (30 Days)
  • SRDX 69.7K
  • VHI 16.0K
  • Earning Date
  • SRDX 07-30-2025
  • VHI 08-07-2025
  • Dividend Yield
  • SRDX N/A
  • VHI 2.05%
  • EPS Growth
  • SRDX N/A
  • VHI 4465.30
  • EPS
  • SRDX N/A
  • VHI 4.11
  • Revenue
  • SRDX $121,575,000.00
  • VHI $2,112,800,000.00
  • Revenue This Year
  • SRDX N/A
  • VHI $22.20
  • Revenue Next Year
  • SRDX $3.70
  • VHI $7.66
  • P/E Ratio
  • SRDX N/A
  • VHI $3.80
  • Revenue Growth
  • SRDX N/A
  • VHI 7.82
  • 52 Week Low
  • SRDX $26.00
  • VHI $14.10
  • 52 Week High
  • SRDX $42.44
  • VHI $41.75
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 48.86
  • VHI 49.40
  • Support Level
  • SRDX $28.67
  • VHI $15.26
  • Resistance Level
  • SRDX $29.87
  • VHI $15.85
  • Average True Range (ATR)
  • SRDX 0.75
  • VHI 0.59
  • MACD
  • SRDX -0.05
  • VHI 0.10
  • Stochastic Oscillator
  • SRDX 26.60
  • VHI 57.96

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About VHI Valhi Inc.

Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management services through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment, which produces and markets value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to various products, including paints, plastics, paper, fibers, and ceramics. Geographically, the company generates maximum revenue from the United States and also has a presence in Germany, Canada, Norway, and Belgium.

Share on Social Networks: